Fariborz Kamal - 01 Sep 2022 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Operating Officer, Chief Technical Officer
Signature
/s/ August J. Moretti, Attorney-in-Fact for Fariborz Kamal
Issuer symbol
FDMT
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
4
Filing time
06 Sep 2022, 20:40:00 UTC
Previous filing
03 Feb 2022
Next filing
27 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +60,000 $0.000000 60,000 01 Sep 2022 Common Stock 60,000 $8.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Remarks:

Chief Operating Officer, Chief Technical Officer